FdaApplication
ANDA 220483
Identifiers
- fda_app_no: ANDA220483
Properties
| Property | Value |
|---|---|
| applicant_name | SAGENT PHARMACEUTICALS |
| application_type | ANDA |
| approval_date | 2026-03-26 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE | NOREPINEPHRINE BITARTRATE | EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) | SOLUTION;INTRAVENOUS |
1 product